Literature DB >> 15744705

Sequestered plutonium: [Pu(IV){5LIO(Me-3,2-HOPO)}2]--the first structurally characterized plutonium hydroxypyridonate complex.

Anne E V Gorden1, David K Shuh, Bryan E F Tiedemann, Richard E Wilson, Jide Xu, Kenneth N Raymond.   

Abstract

The first single-crystal X-ray diffraction analysis of a hydroxypyridonate plutonium(IV) complex is presented, that of the tetradentate ligand 5LIO(Me-3,2-HOPO) with Pu(IV). The [Pu(IV){5LIO(Me-3,2-HOPO)}(2)] complex crystallizes in the space group Pna2(1) with the asymmetric unit cell containing two unique eight-coordinate plutonium complexes and one perchlorate anion. According to shape measure analysis, the geometry of both Pu centers is closest to a bicapped trigonal prism (C(2v) symmetry, for Pu 1: S(C(2v))=13.48 degrees , S(D(4d))=15.43 degrees , S(D(4d))=16.10 degrees ). The average bond length for the Pu--O(phenolic) is 2.31(4) A, whereas the Pu--O(amide) distances are slightly longer, averaging 2.40(2) A. The preparative chemistry of this compound and the implications of the structure are discussed.

Entities:  

Year:  2005        PMID: 15744705     DOI: 10.1002/chem.200401193

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  4 in total

1.  Metalloprobes: synthesis, characterization, and potency of a novel gallium(III) complex in human epidermal carcinoma cells.

Authors:  Scott E Harpstrite; Julie L Prior; Nigam P Rath; Vijay Sharma
Journal:  J Inorg Biochem       Date:  2007-05-08       Impact factor: 4.155

2.  Siderocalin-mediated recognition, sensitization, and cellular uptake of actinides.

Authors:  Benjamin E Allred; Peter B Rupert; Stacey S Gauny; Dahlia D An; Corie Y Ralston; Manuel Sturzbecher-Hoehne; Roland K Strong; Rebecca J Abergel
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-03       Impact factor: 11.205

3.  In situ beam reduction of Pu(IV) and Bk(IV) as a route to trivalent transuranic coordination complexes with hydroxypyridinone chelators.

Authors:  Korey P Carter; Jennifer N Wacker; Kurt F Smith; Gauthier J P Deblonde; Liane M Moreau; Julian A Rees; Corwin H Booth; Rebecca J Abergel
Journal:  J Synchrotron Radiat       Date:  2022-02-25       Impact factor: 2.616

4.  Evaluation of a 3-hydroxypyridin-2-one (2,3-HOPO) Based Macrocyclic Chelator for (89)Zr(4+) and Its Use for ImmunoPET Imaging of HER2 Positive Model of Ovarian Carcinoma in Mice.

Authors:  Jeff N Tinianow; Darpan N Pandya; Sylvie L Pailloux; Annie Ogasawara; Alexander N Vanderbilt; Herman S Gill; Simon-P Williams; Thaddeus J Wadas; Darren Magda; Jan Marik
Journal:  Theranostics       Date:  2016-02-13       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.